Overview
Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Indication
No indication information available.
Associated Conditions
- Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup A
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| MENQUADFI SOLUTION FOR INJECTION | SIN16454P | INJECTION, SOLUTION | 10 mcg/ 0.5 mL | 3/29/2022 | |
| Menactra®, solution for injection | SIN13922P | INJECTION, SOLUTION | 4 mcg/dose (0.5 ml) | 2/24/2011 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| MENVEO Meningococcal (Groups A,C,W-135 and Y) Oligosaccharide CRM197 solution for injection vial | 393321 | Medicine | A | 9/26/2023 | |
| NIMENRIX Meningococcal (Groups A, C, W-135, Y) Polysaccharide Tetanus Toxoid Conjugate Vaccine, injection vial and diluent syringe | 199742 | Medicine | A | 8/29/2013 | |
| MenQuadfi meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid conjugate vaccine, solution for injection, vial | 325682 | Medicine | A | 10/29/2020 | |
| MENVEO meningococcal (Groups A, C, W-135 and Y) oligosaccharide CRM197 conjugate vaccine | 192696 | Medicine | A | 5/23/2012 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| MENCEVAX AC PWS 500MCG/VIAL | 01962922 | Powder For Solution - Subcutaneous | 500 MCG / VIAL | 8/29/1994 | |
| MENCEVAX AC PWS INJ 2500MCG/VIAL | 01962930 | Powder For Solution - Subcutaneous | 2.5 MG / VIAL | 12/31/1992 | |
| MENOMUNE-A/C/Y/W-135 | aventis pasteur limited | 02161184 | Powder For Solution - Subcutaneous | 2.5 MG / KIT | 8/13/1998 |
| NIMENRIX | 02402904 | Powder For Solution
,
Kit - Intramuscular | 5 MCG / 0.5 ML | 8/22/2013 | |
| MENOMUNE-A/C/Y/W-135 | 00588490 | Powder For Solution - Subcutaneous | 500 MCG / KIT | 12/31/1983 | |
| MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A & C | aventis pasteur sa | 01962892 | Powder For Solution
,
Kit - Subcutaneous | 500 MCG / VIAL | 8/13/1998 |
| MENCEVAX AC PWS 50MCG/VIAL | 01962914 | Powder For Solution - Subcutaneous | 50 MCG / VIAL | 12/31/1992 | |
| MENOMUNE-A/C/Y/W-135 | 01959018 | Powder For Solution
,
Kit - Subcutaneous | 50 MCG / 0.5 ML | 10/29/1993 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.